Navigation Links
NHGRI expands effort to revolutionize sequencing technologies

d make it feasible to sequence a genome for $1,000. The majority of researchers who received NHGRI's initial sequencing technology grants, issued in October 2004, are working on technologies to sequence a genome for $100,000. Both approaches have many complementary elements that integrate biochemistry, chemistry and physics with engineering to enhance the whole effort to develop the next generation of DNA sequencing and analysis technologies.

"It is very important that we encourage and support the variety of sequencing technology projects that hold the most promise for revolutionizing genome sequencing. Each research team brings a unique set of skills and expertise to solving difficult scientific and engineering problems," said Jeffery Schloss, Ph.D., NHGRI's program director for technology development. "The different approaches will likely yield several successful and complementary technologies. It is going to be interesting to see how each technology progresses and which of them can ultimately be used by the average researcher or physician."

"$1,000 Genome" Grants

NHGRI's "Revolutionary Genome Sequencing Technologies" grants have as their goal the development of breakthrough technologies that will enable a human-sized genome to be sequenced for $1,000 or less. Grant recipients and their approximate total funding are:

Richard B. Fair, Ph.D., Duke University, Durham, N.C.
$510,000 (2 years)
"Droplet-Based Digital Microfluidic Genome Sequencing"

The near-term goal of this group is to demonstrate how existing droplet-based microfluidic electro-wetting technology can be modified to perform sequencing by synthesis reaction chemistry. This method allows for smaller volumes of materials to be used as well as the decoupling of synthesis and detection steps, resulting in more efficient automation.

M. Reza Ghadiri, Ph.D., The Scripps Research Institute, La Jolla, Calif. and
Hagan P. Bayley, Ph.D., Oxford Unive
'"/>

Source:NIH


Page: 1 2 3 4 5

Related biology news :

1. NHGRI targets 12 more organisms for genome sequencing
2. NHGRI Selects 13 More Organisms for Genome Sequencing
3. NHGRI announces new sequencing targets
4. NHGRI announces latest sequencing targets
5. NHGRI aims to make DNA sequencing faster, more cost effective
6. International HapMap consortium expands mapping effort
7. Gene expands malarias invasion options
8. MWG Biotech expands siMAX?siRNA portfolio with new scales, lengths and design tools
9. New book expands biological classifications to account for alien life
10. New study expands understanding of the role of RNA editing in gene control
11. NIAID expands capability for influenza research and surveillance

Post Your Comments:
(Date:11/5/2009)...ity have developed synthetic molecules capable of ...V-infected cells, as well as to prostate cancer ce...nal of the American Chemical Society , could lead .... , The molecules called "antibody-recruiting ...uiting molecule targeting prostate cancer" (ARM-P)...
(Date:11/4/2009)...tant to officially endorse green tea as a cancer p... its protective effects, including results of a ne... a journal of the American Association for Cancer ...ncer. , Vassiliki Papadimitrakopoulo, M.D., pro...ead and Neck Medical Oncology at the University of...
(Date:11/4/2009)...ng Beach and Riverside are responsible for a signi... and the true impact of air pollution and ship emi...ed, according to researchers at the University of ...ppears in an online edition of the American Journ...of all childhood asthma cases in Long Beach and si...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2USC study finds big air pollution impacts on local communities 2Operation Rescue Announces Keep It Closed Campaign 53523 1Operation Rescue Announces Keep It Closed Campaign 53523 2TWO NEW KLRI PEER REVIEWED PUBLICATIONS 3A Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause 3B Growth Hormone May Increase Risk 4814 1TWO NEW KLRI PEER REVIEWED PUBLICATIONS 3A Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause 3B Growth Hormone May Increase Risk 4814 2TWO NEW KLRI PEER REVIEWED PUBLICATIONS 3A Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause 3B Growth Hormone May Increase Risk 4814 3Switch to digital mammography leads to increased cancer detection rates 53519 1
...cal rainforest interact with each other and their ...archers report in the Oct. 24 issue of the journal... forest dynamics plot of the Pontificia Universida...orest site associated with the Center for Tropical...th Observatory network (CTFS/SIGEO)., It is diffic...
... positive experience. However, by infecting the co... with a Salmonella strain known for causing human...ife Sciences at Arizona State University have shed... broad implications for understanding embryonic de... in humans. Associate Professor Stuart Newfeld and...
...to the mechanisms that underlie a pathological inc...ished by Cell Press in the October 24th issue of t...opment of new strategies for managing this extreme...t failure. , High blood pressure, heart valve dis...kening of the heart muscle, called myocardial hype...
Other Biology News:Diversity of trees in Ecuador's Amazon rainforest defies simple explanation 2Making flies sick reveals new role for growth factors in immunity 2Making flies sick reveals new role for growth factors in immunity 3Making flies sick reveals new role for growth factors in immunity 4Research uncovers new steps on pathway to enlarged heart 2
(Date:11/5/2009)...ITHERSBURG, Md., Nov. 5 ...financial results for the third quarter ended Sept... million ($0.04 per share) for the three months en...6.8 million ($0.08 per share) in the comparable qu... 30, 2009, GenVec,s net loss was $14.1 million ($0...
(Date:11/5/2009)...N DIEGO, Nov. 5 Imagenet...ay that William Spencer, President and CEO of Imag...the 2nd annual LD MICRO Conference on Thursday, De...Los Angeles. ,, About LD MICRO ,, LD MICRO i...s on finding undervalued companies in the micro-ca...
(Date:11/5/2009)...AHA, Neb., Nov. 5 Transg...unced financial results for the quarter ended Sept...e presented in the tables that follow. ,, Thir...oss of $366,000 or $0.01 per share for the third q...00 or $0.01 per share for the third quarter of 200...
(Date:11/5/2009)...RT WORTH, Texas, Nov. 5 ...nced today that it has entered into a Letter of In...Virtual Health Technologies, Inc. (OTC Bulletin Bo...$1,000,000 in cash and debt, 4,000,000 shares of W... by WNDM on the Veriscrip technology being acquire...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...New Flavor Ingredient Achieves ...ber 28, 2008 Senomyx,Inc. (Nasdaq: SNMX ), a lea...gies to discover and develop novel flavor ingredie...dustries, announced today that it has,received a p...ated to a,milestone achieved by Senomyx under the ...
...n Company,s Website -, TUSTIN, Calif., Oct. 28 P... clinical stage biopharmaceutical,company developi...er and,serious virus infections, today announced t...stor Forum 2008 on Thursday, October 30, 2008 at,3...eld at the Palace Hotel,in San Francisco., A live...
...patients with symptomatic Chronic,Obstructive Pulm...ta show reductions in moderate and severe exacerba...on for marketing authorisation in EU and US expect...ation in the US to be initiated, ZURICH, Switzerl...results from a preliminary analysis of four Phase ...
Other Biology Technology:SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 2SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 3Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008 2Nycomed's Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies 2Nycomed's Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies 3
...urce: Calf thymus Description: Topoisomerase I r...DNA by a transient breakage and rejoining of phosp...ith Topoisomerase I allows molecules to be differe...phoresis (3) . Topoisomerase I is active in the ab...
...A Polymerase I catalyzes the template-directed pol...3 direction. DNA Polymerase I possesses a 3?5 exon... lowers the error rate during DNA replication, and...nables the enzyme to replace nucleotides in the gr...
T7 RNA Polymerase from Invitrogen
T7 RNA Polymerase from Roche Applied Science
Biology Products: